OCT4, Ki-67 and VEGF as Prognostic Factors in Endometrial Carcinoma and Their Role in The Differentiation between Atypical Endometrial Hyperplasia and Grade 1 Endometrial Carcinoma: an Immunohistochemical study - Egyptian Knowledge Bank

158662

OCT4, Ki-67 and VEGF as Prognostic Factors in Endometrial Carcinoma and Their Role in The Differentiation between Atypical Endometrial Hyperplasia and Grade 1 Endometrial Carcinoma: an Immunohistochemical study

Article

Last updated: 22 Jan 2023

Overview Similar Items

Article

Stratification of Endometrial Carcinoma Patients Using Immunohistochemistry for Better Surgical Planning and Prognosis

Article

EpCAM Expression in Epithelial Ovarian Cancer: Immunohistochemical and Histopathological Study

Article

Prognostic and Predictive Significance of EpCAM and SOX2 expression in Serous Ovarian Carcinoma

Article

EVALUATION OF SLUG IMMUNOHISTOCHEMICAL EXPRESSION IN ENDOMETRIAL CARCINOMA

Article

IMMUNOHISTOCHEMICAL EXPRESSION OF ESTROGEN RECEPTORS AS PROGNOSTIC MARKER AND CORRELATION WITH CLINICOPATHOLOGICAL PARAMETERS IN HUMAN ENDOMETRIAL ADENOCARCINOMA

Article

p16INKa and Ki67 expression in different grades of cervical intraepithelial neoplasm in relation to HPV genotypes

Article

The prognostic significance of Minichromosome maintenance protein 2 (MCM2) and Trans-glutaminase 2 (TGM2) in Endometrial carcinoma: immunohistochemical and serological study

Article

Clinicopathological and Immunohistochemical Study of High Grade Serous Ovarian Carcinoma

Article

Mismatch repair status in Endometrioid type of Endometrial Carcinoma: association with clinicopathological parameters

Article

The Diagnostic and Prognostic Significance of ARID1A and CD8+ Expression in Endometrial Hyperplasia and Endometrial Endometrioid Adenocarcinoma (Immunohistochemical study)